Finance Watch: Five IPOs Launch In Two Days; Three Remain In Positive Territory

After just 13 biopharmaceutical companies went public in the US during the first four months of 2019, setting a pace of about three per month, five drug developers launched initial public offerings on 7 and 8 May – with mixed results.

Trevi Therapeutics Inc. began the flurry of IPO launches on 7 May, while the other four launched on 8 May. Trevi, which had to discount its offering price to...